Dual or multiple drug loaded nanoparticles to target breast cancer stem cells
Author:
Affiliation:
1. School of Pharmacy
2. Faculty of Medical and Health Sciences
3. University of Auckland
4. Auckland 1142
5. New Zealand
6. Auckland Cancer Society Research Centre
7. Auckland 1023
8. School of Medicine
9. The University of Auckland
Abstract
Breast cancer stem(-like) cells (BCSCs) have been found to be responsible for therapeutic resistance and disease relapse.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA02801K
Reference124 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Progress in adjuvant chemotherapy for breast cancer: an overview
3. Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
4. Breast Cancer: Major Risk Factors and Recent Developments in Treatment
5. Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of size and pH-sensitivity of liposomes on cellular uptake pathways and pharmacokinetics of encapsulated gemcitabine;Journal of Liposome Research;2024-08-09
2. Peptide nanocarriers co-delivering an antisense oligonucleotide and photosensitizer elicit synergistic cytotoxicity;Journal of Colloid and Interface Science;2024-06
3. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells;Journal of Liposome Research;2024-01-25
4. Single-cell Technology in Stem Cell Research;Current Stem Cell Research & Therapy;2024-01-18
5. Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy;Biomacromolecules;2023-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3